Researchers review the role of intratumoral microbiota in cancer development, suggesting its potential in predicting and treating various cancers.
Samsung Biologics hits revenue high, secures largest contract to date
Samsung Biologics closed 2024 on several high notes, reaching its highest annual revenue to date — and just a week ago, securing its largest client